News

Today’s spotlight shines on Kristin Schultz-Kuszak, Associate Director at AstraZeneca.

In 2023, the following initiatives became program highlights and served as opportunities to engage our members in new and meaningful ways.

We are grateful for your participation in our community throughout each year, so we dedicate March to ensure we publicly show our appreciation for all members of CASSS.

This year, we highlight three emerging professionals who played key roles in the speed of the development of the COVID-19 vaccine during the pandemic.

This White Paper on "Comparability for Cell and Gene Therapy Products" will provide you with an overview from CGTP Summit 2023.

CASSS thanks four former Board Members who served in 2023 that are no longer serving in 2024.

CASSS has honored Wassim Nashabeh, PhD with its prestigious Hancock Award for Outstanding Achievement in CMC Regulatory Science.

CASSS is excited to announce thirty-four new Associate Directors (ADs) will be joining the CASSS leadership.

CASSS is excited to announce the election of Christof Finkler, Nomalie Jaya, Andy Weiskopf, and Heidi Zhang to the Board of Directors.

The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on James Carroll, Sr. Director at Pfizer, Inc.